CAMBRIDGE, MASS. - Novartis AG will lease the entire 255,000-sf Technology Square building and 150,000 sf nearby to establish the
Novartis Institute for Biomedical Research in Cambridge. The Swiss pharmaceutical giant, Europe's third-largest drug manufacturer, will invest $255-million in the worldwide research headquarters that will eventually house 900 scientists.
Printer Friendly Version
Send to a Friend
